Bristol-Myers Squibb Company Ce Goodwill

Bristol-Myers Squibb Company Ce posts a goodwill of $8B as of September 2019. That compares with $8B in the prior-year period — up 0.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bristol-Myers Squibb Company Ce's goodwill was $8B. The latest reading is $8B — essentially flat versus a year earlier (period ending September 2019). Use the history and growth charts on this page for a longer lookback.

Goodwill is one piece of Bristol-Myers Squibb Company Ce's financial statement story. At $8B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CELG-RI's goodwill usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Bristol-Myers Squibb Company Ce's other metric pages and overview cover the third.